Mesenchymal stem cells ameliorate lipid metabolism through reducing mitochondrial damage of hepatocytes in the treatment of post-hepatectomy liver failure
Open Access
- 21 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 12 (1), 1-15
- https://doi.org/10.1038/s41419-020-03374-0
Abstract
Hepatectomy is an effective therapeutic strategy for many benign and malignant liver diseases, while the complexity of liver anatomy and the difficulty of operation lead to complications after hepatectomy. Among them, post-hepatectomy liver failure (PHLF) is the main factor threatening the life of patients. At present, liver transplantation is an effective approach for PHLF. However, the application of liver transplantation has been largely limited due to the shortage of donors and the high cost of such operation. Therefore, it is urgently necessary to develop a new treatment for PHLF. Mesenchymal stem cells (MSCs) have become a new treatment regimen for liver diseases because of their easy access and low immunogenicity. Our study found that there were some subtle connections between MSCs and liver lipid metabolism in the PHLF model. We used MSC transplantation to treat PHLF induced by 90% hepatectomy. MSC transplantation could restore the mitochondrial function, promote the β-oxidation of fatty acid (FA), and reduce the lipid accumulation of hepatocytes. In addition, interleukin 10 (IL-10), a cytokine with immunoregulatory function, had an important role in lipid metabolism. We also found that MSCs transplantation activated the mammalian target of rapamycin (mTOR) pathway. Therefore, we explored the relationship between mitochondrial damage and lipid metabolism abnormality or PHLF. MSCs improved mitochondrial function and corrected abnormal lipid metabolism by affecting the mTOR pathway in the treatment of PHLF. Collectively, MSC transplantation could be used as a potential treatment for PHLF.Keywords
This publication has 42 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric PerspectiveOxidative Medicine and Cellular Longevity, 2014
- AMPK alpha 1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expressionJournal of Hepatology, 2013
- Lipid overloading during liver regeneration causes delayed hepatocyte DNA replication by increasing ER stress in mice with simple hepatic steatosisThe Esophagus, 2013
- Mesenchymal Stem Cells in Tissue RepairFrontiers in Immunology, 2013
- Functional Relationships between Lipid Metabolism and Liver RegenerationInternational Journal of Hepatology, 2012
- Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomyJournal of Hepatology, 2011
- Vascular IL-10: a protective role in preeclampsiaJournal of Reproductive Immunology, 2011
- The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosisThe EMBO Journal, 2011
- Lipid Analysis Reveals Quiescent and Regenerating Liver‐Specific Populations of Lipid DropletsLipids, 2010
- The Preservation of Hair in Burns of the ScalpPlastic and Reconstructive Surgery, 1983